**I have long felt the short did have many opportunities to jump off Kerx and cover. I really do think they overstayed their welcome. I am beginning to wonder if Seth is setting up a liaison of "strong" hand HF's, by simply following his lead. A "strengthening" of the shareholder base.. Do we have a KBIO situation in the making? Still about 28 million shares short and not nearly enough shares out there to cover when we get a spark.
**I expected an EU partner announcement in October, what I did not know at the time was that Seth was going to become a Sugar Daddy for Kerx. So now I have shifted my timeline to early December. I"m sure we received some overtures before and after EU approval that simply were not acceptable. Sending BP back to the drawing board.I still feel SNY will step up and be the one who will make the deal, now that it appears they have committed to their renal division. (all of the sudden). Let me say this: IF we do not have a partner by the end of this year, the whole company will be sold as one. US/UK etc. Time is $ in the EU and SNY sales sliding in W. Europe
**I am still uncomfortable with our efforts in the US. I just feel we have not put our best foot forward with a high powered VP of Sales. My sense is the field feels that they are in a lame duck status,hence we are not seeing huge strides in script growth. Big turnover. There are rumbles that reps are walking,. even the few good ones. (not confirmed by a credible source) Last time I checked there were still a lot of positions yet to be filled in key markets.
**As mentioned before, the alleged cost cutting moves have to come from the corporate office and perhaps the NYC office closing. I want more details on this. Could reveal some things about the future of Kerx as a stand alone entity.
**What other asset does GM have in mind?? Shield? Another drug in trial? We know it's not going to be another office.Could be just a smoke screen.
Happy Thanksgiving All
We KNOW it's a good stock that will be in high demand for shares to cover. Low volume trading days later this week could produce some big block trades into the closing today. Next week could be very interesting with the strong possibility of an EU announcement in early December.
Nicely done Abbey. Hopefully you will be able to pick up your check early next year.
Based on that insider buy by the CFO. Now looking for something between 12/6 and end of year.
Cafe, I agree. I have felt that as well. When was the last time a MB had it all figured out , good or bad?
There is almost always an element of surprise .
I´ve some very good new for all Kerx longs
1) Doug and his parrot are back on track
2) and so are the IMS scripts 11/13 for Auryxia
Despite Veterans day and the 2nd week syndrom ;-) IMS TRX is 354
btw last week 359 for all those are interested Less
Sentiment: Strong Buy
Still feel the same about this. Just to add to my suspicion ........ Kerx is undergoing a significant cost cutting initiative while adding to the field. Unless the NYC rent is so huge and would comprise the lions share of the cost cutting measure, why would a company cut their infrastructure at this stage of growth?
Some may say they hired too aggressively , anticipating a much stronger launch or they are getting rid of payroll that may be deemed redundant if acquired. My experience has shown that companies that begin start trimming support departments are either in big trouble or staging for a sale.
IDK, maybe there's alot of hedge funds based out of Boston. Just seems to be a disproportionate amount with Kerx, who happened to move to Boston for "some" reason. I live in Boston. Would be happy to host you goofy bahstahds.
It's huge because this is not what their initial strategy was.supposed to be. They stated that their target patient was going to be new to dialysis. The fact that they are converting a tough to convert group is encouraging.
Not bad. Aren't they targeting about 6k physicians? 30% targeted have written so far......